Brief: Committee For Medicinal Products Has Adopted Negative Opinion On BioArctic's Lecanemab For EU

BioArctic AB (publ)

26/07/2024 11:43

July 26 (Reuters) - BioArctic AB  BIOAb.ST :
    * CHMP HAS ADOPTED A NEGATIVE OPINION ON LECANEMAB FOR THE
EU
    * IS CURRENTLY CONSULTING EISAI REGARDING FORTHCOMING
ACTIONS
    * FURTHER UPDATE WILL BE COMMUNICATED LATER TODAY
    * BIOARCTIC HAS RIGHT TO COMMERCIALIZE LECANEMAB IN NORDIC
REGION

Source text for Eikon:  ID:nWkr48cMxW 
Further company coverage:  BIOAb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))